P3 Health Partners (NASDAQ:PIII) Posts Earnings Results, Misses Estimates By $14.96 EPS

P3 Health Partners (NASDAQ:PIII) announced its quarterly earnings results on Thursday. The company reported ($23.02) earnings per share for the quarter, missing the consensus estimate of ($8.06) by ($14.96), FiscalAI reports. The company had revenue of $384.81 million during the quarter, compared to analysts’ expectations of $357.65 million. P3 Health Partners had a negative net margin of 9.07% and a negative return on equity of 302.33%.

P3 Health Partners Trading Down 10.3%

NASDAQ:PIII traded down $0.32 during midday trading on Thursday, reaching $2.79. 35,670 shares of the stock traded hands, compared to its average volume of 89,501. The stock has a market capitalization of $20.12 million, a P/E ratio of -0.07 and a beta of 0.86. P3 Health Partners has a 12 month low of $1.52 and a 12 month high of $11.30. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.32 and a current ratio of 0.32. The company has a fifty day moving average of $2.48 and a 200 day moving average of $5.25.

Wall Street Analyst Weigh In

PIII has been the topic of a number of recent analyst reports. BTIG Research reaffirmed a “neutral” rating on shares of P3 Health Partners in a research note on Friday, December 12th. Weiss Ratings reissued a “sell (e+)” rating on shares of P3 Health Partners in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $12.50.

About P3 Health Partners

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.